CDSCO releases regulatory guidelines for sampling of drugs, cosmetics and medical devices Ruchika Sharma19 Feb 2024 6:30 PM ISTNew Delhi: In order to streamline and rationalize the sampling procedure of drugs, cosmetics and medical devices and maintaining a centralized monthly...
Should Nutraceuticals be brought under CDSCO? Government forms panel to decide Ruchika Sharma19 Feb 2024 11:30 AM ISTOfficials said due to unsupervised usage of supplements, people at the same time consume supplements along with drugs which might interact with each...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study Capivasertib Plus Abiraterone Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel grants Sanofi's Updated Prescribing Information for FDC Ibuprofen plus Paracetamol Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Rejects Dr Reddy's Proposal to Study FDC of Ketorolac plus Serratiopeptidase Capsules Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: Citing there is no rationality of the combination and significant benefits, the Subject Expert Committee (SEC) functional under the...
By Doctors' Prescription only: Oseltamivir and Zanamivir added into Schedule H1 Drugs Dr. Divya Colin17 Feb 2024 6:00 PM ISTNew Delhi: Through a recent gazette notification, the Ministry of Health and Family Welfare, Government of India, has placed Oseltamivir and Zanamivir...
Sun Pharma Gets CDSCO Panel Nod to Study Tildrakizumab Injection 100 mg/ ml Dr. Divya Colin16 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Safety Data From Phase I CT : CDSCO Panel Tells Novo Nordisk on CagriSema Dr. Divya Colin14 Feb 2024 6:00 PM ISTNew Delhi: Reviewing the Phase II clinical study protocol of CagriSema, a combination medication that includes semaglutide and Cagrilintide, the...
CDSCO approves Jardiance for treatment of adults with chronic kidney disease in India Ruchika Sharma14 Feb 2024 5:49 PM ISTMumbai: The national regulatory authority of India, the Central Drugs Standard Control Organisation (CDSCO), has approved Jardiance...
Akums Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin13 Feb 2024 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel rejects Synokem proposal for FDC of Mecobalamin, Nortriptyline, Pregabalin Dr. Divya Colin12 Feb 2024 6:00 PM ISTNew Delhi: Citing that the proposed fixed-dose combination (FDC) of Mecobalamin IP 1500mcg plus Nortriptyline Hydrochloride IP Eq. to Nortriptyline...
Modify Clinical Study Protocol: CDSCO Panel Tells Roche On Multiple Sclerosis Drug Ocrelizumab Dr. Divya Colin11 Feb 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by drug major Roche to conduct the Phase IV clinical trial for the drug product Ocrelizumab 300 mg...
